Table 2 Clinical characteristics of the subjects.
Parameters | Covid−19 group (n = 44) | Control group (n = 11) | P value | |
|---|---|---|---|---|
Critical (n = 22) | Moderate-Severe (n = 22) | |||
Gender (male/female) | 17/5 | 16/6 | 8/3 | 0.363 |
Age (years) | 72.0 (36.0–92.0) | 67.5 (46.0–92.0) | 72.0 (58.0–84.0) | 0.727 |
Fever | 20/22(90.9%) | 22/22(100%) | — | 0.148 |
Sore throat | 1/22(4.5%) | 0 | — | 0.312 |
Cough | 16/22(72.7%) | 19/22(86.4%) | — | 0.262 |
Sputum production | 12/22(54.5%) | 17/22(77.3%) | — | 0.112 |
Dyspnea | 16/22(72.7%) | 11/22(50%) | — | 0.122 |
CXR scoring | 16 (12, 17) | 11.5 (10, 14) | — | 0.002 |
Duration from symptom onset to sampling (Days) | 5 (4, 5) | 4 (3, 5) | — | 0.148 |
